Cell culture and animal experiments have found that TCMs play anticancer roles by regulating APC/β-catenin, GSK-3β/β-catenin, and ß-catenin/TCF4 pathways which represent the main elements of the Wnt/β-catenin pathway involved in the treatment of CRC. This evidence concerns the gene TCF4 and colorectal carcinoma.